Wednesday, September 19, 2007

[EQ] The e-learning Course on Strengthening of Essential Public Health Functions

 

The e-learning Course on Strengthening of Essential Public Health Functions

From November 14, 2007 to March 19, 2008

URL: http://www.paho.org/English/DPM/SHD/HR/ephf-2ecourse08-wbi-paho.htm#application

Application Form: http://info.worldbank.org/etools/wbi_learning/sec/form_e.cfm?sch_id=HNP08-01-188

The course develops leadership and competencies in the assessment and performance of the 'Essential Public Health Functions' (EPHF), and contribute to the strengthening of effective national public health systems.

Registration deadline is October 1, 2007

Participants: Technical cadres of Ministries of Health, mid-level policy makers, World Bank staff, PAHO and WHO staff, other development agency and donor agency staff and other agents of change.

Organizers: The World Bank Institute and the Pan American Health Organization, PAHO/WHO

Language: English only

Course Structure:

The course is structured around the 11 Essential Public Health Functions as identified by PAHO and will be clustered in an introductory module and 3 tracks.

  • Introductory Module
  • Track 1: Basis and Organization
    1. Health Situation Monitoring
    2. Surveillance and Risk Control
    3. Human Resource Development
    4. Emergencies and Disasters

  • Track 2: Strategy and Policy
    1. Policy Development
    2. Regulation
    3. Health Promotion
    4. Research

  • Track 3: Access and Quality
    1. Quality of Services
    2. Equitable Access
    3. Social Participation
    4. Inter-sectoral Action for Health

Duration and Course Load: Three tracks of 5, 4 and 4 weeks respectively - 8 to 10 hours per week..

Dates:
Track 1:
14 November - 19 December, 2007 (5 weeks)
Track 2: 9 January - 6 February, 2008 (4 weeks)
Track 3: 20 February - 19 March, 2008 (4 weeks)

Course Format:

Students will take the course entirely through the internet (World Wide Web). Upon acceptance as participant you will be given a course ID and password, with which you will be able to access the course site. The format of the course relies heavily on 'action learning' which means that you will be required to actively participate in all online activities, which will mainly consist of reading the course content and posting assignments and reacting to other participants' postings.
As most of the weeks' assignments are based on team work and joint products, it is imperative that you are able to log in and work on the course regularly so that your team can effectively produce the team products, and that you can adhere to deadlines. Active participation is required to qualify for receiving a completion certificate.

General Course Contact: Jo Hindriks at jhindriks@worldbank.org

 

 

 *      *      *     * 
This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ IKM Area] 

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.

---------------------------------------------------------------------------------------------------

PAHO/WHO Website: http://www.paho.org/

EQUITY List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

 

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.  

[EQ] Conference: The Global Organisation of Biomedical Innovation: Funding, Intellectual Property Rights, Incentives and the Diffusion of New Technology

ESF-IfW Conference on The Global Health Economy:


The Global Organisation of Biomedical Innovation:
Funding, Intellectual Property Rights, Incentives and the Diffusion of New Technology


Kiel, Germany 4-8 October 2007

 

Chair: Frederic M. Scherer, John F. Kennedy School of Government, Harvard University, US

Vice-Chair: M.N. Graham Dukes, University of Oslo, Norway

 

Website:  http://www.esf.org/conferences/07247   With support from www.esf.org

 


"….Biomedical innovation is likely to be the most important source of future gains in quality of life and longevity worldwide and represents the socially most valuable major investment opportunity at the beginning of the 21st century.

The process of globalization has enhanced that opportunity by extending the scale at which economies of scale in the generation and diffusion of new medical knowledge and technology can be exploited. To do so more efficiently will require the reorganization of a wide variety of activities, institutions and regulations that determine how well the private incentives are aligned with the global priorities in maximizing human welfare. Particular emphasis will have to be placed on novel knowledge management systems that allow the social benefits and risks of new therapies to be predicted with greater accuracy and earlier in the development process of biomedical technologies…."

 

Final Programme


Friday – 5 October

Session 1: Demand, Supply, Government Funding and Private Insurance in the Global Market for Biomedical Innovation

Chair: M.N. Graham Dukes, University of Oslo, NO

Félix Lobo Universidad Carlos III de Madrid, ES

Science and Regulation – How Market Regulations Increasingly Depend on Science. The Case of the European Union

Frederic M. Scherer Harvard University, Cambridge, US

Coping with Uncertainty in Pharmaceutical Development

Charles Abraham Yankah German Heart Institute Berlin, DE

The Role of Translational Medicine in Accelerating Biomedical Innovation

Darius Lakdawalla RAND Corporation, Santa Monica, US

Can A Competitive Health Insurance Market Set Optimal Incentives for Biomedical Innovation?

Rainer Sauerborn University of Heidelberg, DE

The Optimal Financing and Organisation of Health Care in Low and Middle Income Countries

Ayesha Aftab World Health Organization, Riwalpindi, PK

Health Care Responsive Budgeting – Evolving Linkages between Public and Private Investment

Carsten M.H. Claussen Evotec Technologies GmbH, Hamburg, DE

 

Session 2: Intellectual Property Rights and International Trade

Chair: Frederic M. Scherer, Harvard University, US

Carlos M. Correa University of Buenos Aires, AR

Diffusion of Medical Technology and Intellectual Property Rights in Latin America

Ove Granstrand Chalmers University of Technology, Göteborg, SE

The Role of Intellectual Property Rights in Biomedical Innovation

James Love Consumer Project for Technology, Washington DC, US

Prospects for a Global Treaty to Govern Biomedical Research

Ellen ‛t Hoen Médecines Sans Frontières, Paris, FR

Access to Innovative Medicines in Poor Countries – Developing a Policy Strategy

Jayashree Watal WTO, Geneva, CH

The TRIPS Agreement and Public Health – with a Focus on the Paragraph 6 System of the Doha Declaration

Naomi Hawkins The Ethox Centre, University of Oxford, UK

The Impact of Patents on the Translation of Research into Clinical Application in the Context of Genetic Diagnostics

Daniel Maceira Center for the Study of State and Society, CEDES, Buenos Aires, AR

Pharmaceutical Product Regulation in Argentina – Organizational Structure and Comparative Performance

Kathrin Adlkofer Norgenta, Life Science Nord, Hamburg, DE

 

Saturday – October 6

Session 3: The Social Returns to Biomedical Research

Chair: Dietmar Harhoff, University of Munich, DE

Joseph diMasi Tufts University, Boston, UK

Trends in Post-approval Pharmaceutical R&D – Dissecting the Data on Line Extensions

Frank R. Lichtenberg Columbia University, New York, US

International Medical Technology Diffusion

Ronald J. Gilson Stanford University, US

Fostering Successful Venture Investing in Biotechnology – Lessons for Europe

Simcha Jong University College London, UK

Academic Institutions and Spin-Off Firms in the Life Sciences – Berkeley,Stanford and UCSF and the Birth of the Biotechnology Industry

Rainer Sauerborn University of Heidelberg, DE

 

Session 4: The Fragile State of Europe's Biomedical Industry

Chair: Michael Stolpe, Kiel Institute for the World Economy, DE

Liselotte Højgaard Rigshospitalet Copenhagen, DK, and Chair, European Medical Research Councils

Present Status and Future Strategy for Medical Research in Europe

Fabio Pammolli University of Florence, and Director, IMT Lucca Institute for Advanced Studies, IT

European Pharmaceutical Innovation and Regulatory Systems

Dietmar Harhoff University of Munich, DE

Comparing the German and the British Biotechnology Industries – Finance, Management and Regulation

Maureen McKelvey Chalmers University of Technology, Göteborg, SE

Managing Bioengineering Companies – A European Perspective

Luigi Orsenigo University of Sussex, SPRU, UK and Bocconi University, IT

Knowledge Accumulation, Regulation, and Appropriability in Europe's Pharmabiotech Industry

Koen Wiedhaup Netherlands Genomics Initiative, NL

Public and Private Sector Interaction in Promoting Biomedical Innovation

Timm-H. Jessen Bionamics GmbH, Kiel, DE

 

Sunday – October 7

Session 5: Health Care Institutions, Investment Incentives, and the Diffusion of Innovations

Chair: M.N. Grahem Dukes, University of Oslo, NO

Yelzhan Birtanov Institute for Healthcare Development, Almaty, KZ

Ensuring Therapeutic Advance in a Transitional Economy

Ramanan Laxminarayan Resources for the Future, Washington DC, US

Antimicrobial Drug Resistance: An Agenda for Research and Policy

Tbc Samira Humaira Habib University of Dhaka, BD

Cost-effectiveness Analysis of Medical Intervention in Patients with EarlyDetection of Diabetic Foot in a Tertiary Care Hospital in Bangladesh

Alireza Haghighi University of Oxford, Nuffield Department of Clinical Medicine, UK

The Role of Diaspora in Medical Knowledge and Technology Transfer to Developing Countries – A Network Model

Nicola Leaney Phoenix Biologix Pty Ltd, Broadway, AU

Sustainable Manufacturing for Developed Countries – How to Cooperate with Emerging Economies

Wolf Rogowski GSF National Research Centre for Environment and Health, Neuherberg, DE and University of York, UK

Key Features for Monitoring and Comparing Fourth Hurdle Institutions

Peter Zweifel Socioeconomic Institute, University of Zürich, CH

The Influence of Insurance on Biomedical Innovation

Alexander Jean Luc Coad Max-Planck-Institute of Economics, Jena, DE

The Co-Evolution of Sales Growth, Employment Growth and Growth of R&D Expenditure

Pedro Luis Sanchez Farmaindustria, Madrid, ES

Prices and Penetration of Pharmaceutical Innovations – An International Comparison

 

 

 

Conferences on The Global Health Economy is supported by an academic advisory council that comprises leading scholars in the fields of medicine, health economics and related sciences and a number of leading representatives from German health care finance, industry and politics.

These include

· Ulrike Beisiegel, Director of the Institute for Biochemistry and Molecular Biology at the Eppendorf Research Hospital of the University of Hamburg,

· Norbert Klusen, Chairman of the Board of Techniker Krankenkasse, Hamburg, Germany's most innovative sickness fund,

· Hellmut Körner, Secretary of State for Social Affairs, Health, and Family Policy in Schleswig-Holstein,

· Heiner Raspe, Director of the Institute for Social Medicine at the Medical University of Lübeck,

· Wolfgang Reim, former President and Chief Executive Officer of Dräger Medical AG & Co. KG, a Dräger and Siemens Company, and Member of the Board of Drägerwerk AG, Lübeck,

· Ernst Theodor Rietschel, President of the Leibniz-Gemeinschaft, one of Germany largest research organizations with an extensive research portfolio in both medicine and economics and a total of 84 autonomous research institutes,

· Stefan Schreiber, Director of the Institute for Clinical Molecular Biology at the University of Kiel and Director of the German National Genome Research Network,

· J.-Matthias Graf von der Schulenburg, Director of the Institute for Insurance Economics and Director of the Research Center for Health Economics and Health Systems Research at theUniversity of Hannover, and

· Dennis Snower, Ph.D., President of the Kiel Institute for the World Economy and Chair of the Department for Economic Theory at the University of Kiel.

 

 

 *      *      *     * 
This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ IKM Area] 

"Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members".

---------------------------------------------------------------------------------------------------

PAHO/WHO Website: http://www.paho.org/

EQUITY List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

 

 

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.  

[EQ] Trade in Health Services - An Analytical Framework

Trade in Health Services - An Analytical Framework


Patricia Waeger, July 2007

Advanced Studies in International Economic Policy Research

Kiel Institute for the World Economy - Kiel/Germany - Working Paper No. 441

 

Available online as PDF file [34p.] at: http://www.ifw-kiel.de/asp/aspwp/2007/aspwp441.pdf

 

“…..The present paper deals with a topic that pertains to Health Economics as well as to Trade Theory – Trade in Health Services. It is intended to deliver an analytical framework for the assessments of this new sector of international trade which takes into account both the ‘general welfare aspects’ and the effects for the achievement of general ‘health system goals’.

 

While to former will be scrutinized by the subcategories allocation, accumulation and location effects, the latter is aligned with the OECD Health System Performance Framework which mentions three major health system goals that are:
- Health Improvement & Outcome
- Responsiveness & Access and
- Financial Contribution & Health Expenditures

 

For this purpose trade in Health Services is split up according to the four modes of service supply introduced by the General Agreement of Trade in Services (GATS). For each mode examples are enclosed and the current level of trade is analysed. It is also examined what are the major obstacles for trade in these

modes and what liberalization perspectives are given. The subsequent discussion and plausibility considerations of how each mode may contribute to improve efficiency as well as equity in national health systems is a systematic starting point for further research. It provides a first insight in how trade in Health Services could help to overcome resource constraints in national health systems as well as allude to the potential risks of which sight shouldn’t be lost….”

 

 

 

 *      *      *     * 
This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ IKM Area] 

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.

---------------------------------------------------------------------------------------------------

PAHO/WHO Website: http://www.paho.org/

EQUITY List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

 

 

 

 

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.